Nautilus Biotechnology, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Nautilus Biotechnology, Inc. (NAUT) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $15.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- Nautilus Biotechnology, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $15.00M, a 25.74% decline from fiscal 2024.
- Nautilus Biotechnology, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $20.20M, a 18.82% increase from fiscal 2023.
- Nautilus Biotechnology, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $17.00M, a 0.58% decline from fiscal 2022.
- Nautilus Biotechnology, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $17.10M, a 13.25% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $15.00M 10-K · filed 2026-02-26 |
| 2024-12-31 | $20.20M 10-K · filed 2026-02-26 |
| 2023-12-31 | $17.00M 10-K · filed 2025-02-27 |
| 2022-12-31 | $17.10M 10-K · filed 2024-02-28 |
| 2021-12-31 | $15.10M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |